ASX Health Stocks: Telix seeks FDA approval for Illucix; Chimeric releases viral vector
[ad_1] Telix Pharma’s Illucix could be utilised in BgRT radiotherapies in the US Chimeric Therapeutics innovations its Automobile T treatment application Telix expands partnership with